Acuity Medical, Inc. – Trademark Portfolio

Entity Type: 03

Acuity Medical, Inc. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 5 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include EZ BOARD and TRANSMOTION. The owner is based in Minneapolis, MN.

3565 IDS Center

80 South Eighth Street

Minneapolis, MN 55402

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Acuity Medical, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (5 filings)

Surgical, medical, dental and veterinary apparatus and instruments

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does Acuity Medical, Inc. have?

Acuity Medical, Inc. has 5 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned, 2 cancelled.

What trademark classes does Acuity Medical, Inc. file in?

Acuity Medical, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 44 (Medical Services). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Acuity Medical, Inc.'s most well-known trademarks?

Acuity Medical, Inc.'s registered trademark portfolio includes well-known marks such as EZ BOARD and TRANSMOTION. These are among 2 currently registered trademarks in the portfolio.

What is Acuity Medical, Inc.'s trademark registration success rate?

Acuity Medical, Inc. has a 40% trademark registration rate, with 2 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.